Tag Archive for: Sarcomas

An Interesting Reconstruction Option after Resection for a Distal Fibular Osteosarcoma: A Case Report

Case Report | Volume 6 | Issue 1 | JBST  Jan-April 2020 | Page 13-16 | DOI: 10.13107/jbst.2020.v06i01.008

Author:  Manish Pruthi [1], Jagandeep Singh Virk [2], Lokesh Garg [1], Sumit Goyal [4], Anila Sharma [3]

1. Department of Orthopaedic Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi,Delhi, India,
2. Department of Orthopaedic Oncology, Paras Hospitals, Panchkula,Haryana, India,
3. Department of Pathology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, Delhi, India,
4. Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi,India

Address of Correspondence
Dr. Jagandeep Singh Virk,
Department of Orthopaedic Oncology, Paras Hospitals, Panchkula,Haryana, India.
E-mail: jaganvirk_09@yahoo.co.in

Abstract

Fibula is an expandable bone in the body, but tumors arising from the distal part which require a wide resection of the distal fibular part require some form of reconstruction for preventing lateral ankle instability. Many methods involving either bony or soft tissue reconstruction techniques have been described in literature, but consensus regarding which one is optimal for a good oncological and functional outcome is lacking. In this case report, we make use of a biological soft tissue technique involving use of peroneus brevis autograft reconstruction for providing lateral ankle support for a patient suffering from distal fibular osteosarcoma who underwent resection of the distal fibula. The patient went on to have an excellent functional outcome. This technique, although reported in literature, is in the form of only a few cases with a limited follow-up with none reported from the Indian subcontinent.
Keywords: Fibula, Sarcomas, Limb salvage, Reconstruction.

References

1. UnniKK. Dahlin’s Bone Tumors: General Aspects and Data on 11087 Case. 5th ed. Philadelphia, PA: Lippincott-Raven; 1996. p. 1-9.
2. PerisanoC, MarzettiE, SpinelliMS, GraciC, FabbricianiC, MaffulliN, et al.Clinical management and surgical treatment of distal fibular tumours: A case series and review of the literature.Int Orthop2012;36:1907-13.
3. SchneiderbauerMM, GullerudR, HarmsenWS, ScullySP. Fibular osteosarcomas: Contaminated margins may not impact survival.Clin OrthopRelat Res2007;456:182-7.
4. LaitinenM, HardesJ, AhrensH, GebertC, LeidingerB, LangerM, et al. Treatment of primary malignant bone tumours of the distal tibia.Int Orthop2005;29:255-9.
5. DieckmannR, AhrensH, StreitbürgerA, BudnyTB, HenrichsMP, ViethV, et al.Reconstruction after wide resection of the entire distal fibula in malignant bone tumours.Int Orthop2011;35:87-92.
6. MonsonDK, VojdaniS, DeanTJ, Louis-UgboJ. Lateral ankle stabilization after distal fibular resection using a novel approach: A surgical technique.Clin OrthopRelat Res2014;472:1262-70.
7. EnnekingWF, DunhamW, GebhardtMC, MalawarM, PritchardDJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.Clin OrthopRelat Res1993;286:241-6.
8. MohlerDG, CunninghamDC.Adamantinoma arising in the distal fibula treated with distal fibulectomy: A case report and review of the literature.Foot Ankle Int1997;18:746-51.
9. Norman-TaylorFH, SweetnamDI, FixsenJA. Distalfibulectomy for Ewing’s sarcoma.J Bone Joint Surg Br1994;76:559-62.
10. KanayaK, WadaT, KuraH, YamashitaT, UsuiM, IshiiS.Valgus deformity of the ankle following harvesting of a vascularized fibular graft in children.J ReconstrMicrosurg2002;18:91-6.
11. JonesRB, IshikawaSN, RichardsonEG, MurphyGA. Effect of distal fibular resection on ankle laxity.Foot Ankle Int2001;22:590-3.
12. MannRA, RongstadKM. Arthrodesis of the ankle: A critical analysis.Foot Ankle Int1998;19:3-9.
13. DurakK, BilgenO, KaleliT, AydinliU. Distal fibula resection in osteochondroma.J Int Med Res1996;24:381-6.
14. deGauzy JS, KanyJ, CahuzacJP. Distal fibular reconstruction with pedicled vascularized fibular head graft: A case report.J PediatrOrthop B2002;11:176-80.
15. EgerW, SchörleC, ZeilerG. Giant cell tumor of the distal fibula: Fifteenyear result after en bloc resection and fibula reconstruction.Arch Orthop Trauma Surg2004;124:56-9.
16. PickeringR. Arthrodesis of ankle, knee, and hip. In: PickeringRM, editors. Campbell’s Operative Orthopaedics. 10th ed. St Louis, MO, USA: Mosby; 2003.
17. SaridisAG, MegasPD, GeorgiouCS, DiamantakisGM, TyllianakisME. Dual-fibular reconstruction of a massive tibial defect after Ewing’s sarcoma resection in a pediatric patient with a vascular variation.J PediatrOrthop2011;31:297-302.
18. VaseenonT, SaengsinJ, KamintaA, PattamapaspongN, SettakornJ, PruksakornD.Ankle ligament reconstruction after wide resection of the osteosarcoma of the distal fibula: A case report.BMC Res Notes2017;10:769.

 

How to Cite this article: Pruthi M, Virk J D, Garg L, Goyal S, Sharma A | An Interesting Reconstruction Option after Resection for a Distal Fibular Osteosarcoma: A Case Report | Journal of Bone and Soft Tissue Tumors | January-April 2020; 6(1): 13-16.

[Full Text HTML]    [Full Text PDF] [XML]

M.D.T. (Multi Disciplinary Team) For Sarcomas: A Must !

 

Journal of Bone and Soft Tissue Tumors

Journal of Bone and Soft Tissue Tumors

Vol 1 | Issue 2 |  Sep- Dec 2015 | page:1-2 | Dr. Yogesh Panchwagh & Dr. Ashok Shyam.

Author: Dr. Yogesh Panchwagh [1], Dr. Ashok Shyam [2,3].

[1]Orthopaedic Oncology Clinic, Pune, India.
[2] Indian Orthopaedic Research Group, Thane, India
[3] Sancheti Institute for Orthopaedics &Rehabilitation, Pune, India

Address of Correspondence
Dr. Yogesh Panchwagh.
Orthopaedic Oncology Clinic, 101, Vasanth plot 29, Bharat Kunj Society -2, Erandwana, Pune – 38, India.
Email: drpanchwagh@gmail.com

Editorial: M.D.T. (Multi Disciplinary Team) For Sarcomas: A Must ! 

“Coming together is beginning, keeping together is progress, working together is success”: Henry Ford.

Henry Fords quote can be aptly extrapolated to the clinicians working in the field of orthopaedic oncology. Many a time, it is seen that interaction between various specialties is of paramount importance to reach to a logical conclusion while dealing with bone and soft tissue tumors. The rarity of these lesions and often-encountered complex clinical scenarios makes it mandatory for the treating clinicians to sit together to decide the diagnosis and further line of management. The multi disciplinary team (M.D.T.) that thus ensues is the key to success in management of bone and soft tissue tumors.
A typical M.D.T. comprises of (but may not be limited to) the sarcoma surgeons, medical and radiation oncologists, Pathologists, radiologists, Palliative care and rehabilitation specialists. It is expected that the institute where the M.D.T. is located should have reasonable experience in managing sarcoma patients. This number may vary from country to country. For example, In the U.K., it is expected that such an M.D.T. should be seeing at least 100 new soft tissue sarcoma cases every year or 25 primary bone sarcoma cases every year [1,3].
It is expected that all cases or suspected cases of sarcomas should have a speedy access to diagnosis and treatment. All diagnosed cases also need to be reviewed by a specialist in the M.D.T. The surgical management including the initial biopsy and definitive resection, chemotherapy and radiotherapy are to be carried out by member of a sarcoma MDT. In case that a surgeon who is a M.D.T. member is not available, the surgery should be done by a surgeon with tumor site-specific or age-appropriate skills, in consultation with the sarcoma MDT. Informing patients about relevant clinical trials and support to enroll into the trials as appropriate also forms a responsibility of the M.D.T [1,2,3,4].
Such MDT’s should be developed at individual centers that specialize in management of sarcomas. The advantages of such MDT approach is manifold. First it will allow complete and detailed assessment of patient and the disease at single center which will help in early and accurate diagnosis of the disease and extent of the disease. It will also help in more precise planning of management strategies and much better patient care. Sarcomas are unique diseases in the sense that they invoke a great sense of anxiety in the patients and their caregivers. These diseases have strong emotional responses and many a times lot of confusion exists in minds of the affected. In our country this leads to a varied response which many a times includes patient being referred and consulted by many doctors and surgeons before reaching a proper channel of care. A single coordinated MDT will help the patients to reach this channel much earlier. A coordinated approach at single center will help curb the patient’s and caregivers anxieties to a large extent and will also be much more convenient to them. The Australian Sarcoma Study Group have gone through the literature and produced evidence supporting MDT approach through following conclusions [1,2,3] :
1. MDT: Treatment at a dedicated MDT center results in better patient survival, decreased amputation risk, better chances of disease free survival. Also MDT center follow the clinical practice guidelines and have appropriate use of preoperative imaging and biopsy.
2. Supportive care: This is one of the most important aspect of patient care that help in providing better care for the patient as a whole. It helps in improving the quality of life, patients stay fewer days in the hospital, require fewer home visits and have better physical, social and emotional responses.
3. In MDT scenario the expert panel of radiologist will be able to diagnose the disease early and also pathological diagnosis is much more accurate in MDT settings.
There have been some attempt to bring together various specialties in our country too. Specifically there have been common forum and meetings where specialties have come together to share their views. Few centers have regular interspeciality meetings too. The Indian Musculoskeletal Oncology Society has organized a multifaculty meeting in Pune in October 2015 and hopefully they will continue to foster this development. Centers that specialize in sarcoma care should realize the importance of MDT approach. Although specialized centers do have coordinated approach, a more formal MDT body will help make the system more organized and effective. Journal of Bone and Soft Tissue supports the multidisciplinary approach and the first issue had authors from almost all specialist involve in sarcoma care. We wish to involve more specialties and specialist involved in sarcoma care with JBST and in coming issues our focus will be to publish articles with more coordinated approach to oncology care.
The MDT approach has been successfully used in many countries. In fact the U.S. National Cancer Control Network (NCCN) (www.nccn.org) and the U.K.s National Institute for Health and Clinical Excellence (NICE) (www.nice.org.uk) both have detailed recommendation for use of MDT approach in management of sarcomas. The developing countries too need to follow a similar model in the interests of the sarcoma patients. It is still not very uncommon in a country like India, which dreams of a digital revolution, to see examples of late diagnosis, improper biopsies, incorrect interventions and non-evidence based management. We believe that there is a need to prepare our own guidelines, modified according to suit the geography, disease prevalence and health care and infrastructural capabilities and to promote the concept of MDT in the care of sarcomas.

Yogesh Panchwagh & Ashok Shyam

References

1. National Institute for Health and Clinical Excellence, 2006. Improving outcomes for people with sarcoma. NICE guidance on cancer services.
2. Robert Grimer Nick Athanasou, Craig Gerrand, Ian Judson, Ian Lewis, Bruce Morland, David Peake, Beatrice Seddon, and Jeremy Whelan. 
UK Guidelines for the Management of Bone Sarcomas. 
Sarcoma. 2010; 2010: 317462.
3. Why Multi disciplinary care is important in sarcomas. www.australiansarcomagroup.org/multi-disciplinary-care.html
4. The ESMO / European Sarcoma Network Working Group. Bone Sarcomas: ESMO Clinical Practice Guidelines. Ann Oncol (2014) 25 (suppl 3): iii113-iii123.

How to Cite this article: Panchwagh Y, Shyam AK. M.D.T. (Multi Disciplinary Team) For Sarcomas: A Must !  Journal of  Bone and Soft Tissue Tumors Sept-Dec 2015; 1(2):1-2.

A B

(Abstract)      (Full Text HTML)   (Download PDF)